Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government

Health Services Research & Development

Go to the ORD website
Go to the QUERI website

IIR 16-072 – HSR&D Study

 
IIR 16-072
Determining and targeting reasons for low statin use to improve guideline-concordant statin therapy in high-risk patients
Salim Virani MD
Michael E. DeBakey VA Medical Center, Houston, TX
Houston, TX
Funding Period: July 2017 - June 2022

BACKGROUND/RATIONALE:
Optimal statin therapy reduces cardiovascular events. We have shown that optimal statin therapy is underused in Veterans with CVD. This can be due to clinical inertia or statin associated side effects which providers usually document in text notes and may not be well captured in structured datasets.

OBJECTIVE(S):
Our objectives are to (Aim 1) identify reasons for suboptimal statin use using structured data and provider text notes using NLP; (Aim 2) understand provider and patient perspectives on statin intolerance and refine a communication aid targeting providers to improve guideline-concordant statin use; and (Aim 3) pilot test an intervention to improve optimal statin use in Veterans with CVD using the communication aid refined in Aim 2.

METHODS:
For Aim 1, we will randomly identify VA patients with CVD on optimal, suboptimal and no statins, and partition them into training and test sets. We will train our NLP system to achieve sensitivity and specificity of >90%, compared with manual chart review to identify reason for suboptimal stain use. In Aim 2, we will conduct interviews with providers and patients to elicit their perspectives on clinical inertia and statin intolerance. These interviews will help refine the communication aid for Aim 3. In Aim 3, we will conduct a pilot trial with Houston and Nashville VAMC PACTs serving as intervention sites. PACTs at intervention sites will receive the communication aid to assist them with statin initiation and/or titration in CVD patients on suboptimal statins. At usual care sites, PACT providers will only receive a quarterly report of the proportion of their CVD patients on suboptimal statins. Our primary outcome is change in the proportion of CVD patients receiving optimal statin therapy.

FINDINGS/RESULTS:
We developed an initial corpus of 465 patients for training/testing the NLP system. We selected notes with standard titles that were most likely to contain documentation of adverse events related to statin usage. We used an iterative process to develop an annotation schema consisting of concepts of interest within the documents. Two nurse annotators identified an initial group of concepts within a small batch of 10-20 documents. Upon completion, annotation was discussed among the research team for further refinement and finalization.
To create document sets for annotation, we used one document from each patient. Documents were stratified so that each set of documents contained approximately 25% African Americans and 75% Non-African Americans, 25% females and 75% males, and 50% were on no statins, 25% on low statin, and 25% on moderate statin. Currently, a total of 171 documents (3 groups of 57) from 171 patients were selected for annotation. Within the first 57 documents, we identified 8 patients with statin-related adverse events, which corresponds to a prevalence rate of 14%.

IMPACT:
Our results identify the vast majority of high-risk Veterans not on optimal statin therapy due to intolerance versus clinical inertia. Our communication aid will identify strategies to initiate or titrate statins in high-risk Veterans. These results will be important for the VA Health Care System to identify patients with "true statin intolerance" who will be future candidates for expensive new drugs recently approved by the FDA.


External Links for this Project

NIH Reporter

Grant Number: I01HX002225-01A1
Link: https://reporter.nih.gov/project-details/9284011

Dimensions for VA

Dimensions for VA is a web-based tool available to VA staff that enables detailed searches of published research and research projects.

If you have VA-Intranet access, click here for more information vaww.hsrd.research.va.gov/dimensions/

VA staff not currently on the VA network can access Dimensions by registering for an account using their VA email address.
    Search Dimensions for this project

PUBLICATIONS:

Journal Articles

  1. Al Rifai M, Mahtta D, Vaughan EM, Petersen LA, Virani SS. Temporal Changes in Cost-Related Medication Nonadherence by Race/Ethnicity and Medicaid Expansion: The Behavioral Risk Factor Surveillance System Survey. Population health management. 2022 Feb 1; 25(1):141-142. [view]
  2. Krittanawong C, Hahn J, Daher M, Mahtta D, Narasimhan B, Wang Z, Bandyopadhyay D, Sharma SK, Alam M, Jneid H, Virani SS. A comparison of cardiovascular risk factors between Asian-Americans and non-Asian Americans: An analysis from the NHANES database. Progress in Cardiovascular Diseases. 2021 Sep 21; 68:94-96. [view]
  3. Maitra NS, Mahtta D, Navaneethan S, Vaughan EM, Kochar A, Gulati M, Levine GN, Petersen LA, Virani SS. A Mistake Not to Be Repeated: What Can We Learn from the Underutilization of Statin Therapy for Efficient Dissemination of Cardioprotective Glucose Lowering Agents?. Current Cardiology Reports. 2022 Jun 1; 24(6):689-698. [view]
  4. Mitchell S, Malanda B, Damasceno A, Eckel RH, Gaita D, Kotseva K, Januzzi JL, Mensah G, Plutzky J, Prystupiuk M, Ryden L, Thierer J, Virani SS, Sperling L. A Roadmap on the Prevention of Cardiovascular Disease Among People Living With Diabetes. Global heart. 2019 Sep 1; 14(3):215-240. [view]
  5. Sajja A, Li HF, Spinelli KJ, Ali A, Virani SS, Martin SS, Gluckman TJ. A simplified approach to identification of risk status in patients with atherosclerotic cardiovascular disease. American journal of preventive cardiology. 2021 Sep 1; 7:100187. [view]
  6. Santo K, Isiguzo GC, Atkins E, Mishra SR, Panda R, Mbau L, Fayomi SB, Ugwu C, Odili A, Virani S. Adapting a club-based medication delivery strategy to a hypertension context: the CLUBMEDS Study in Nigeria. BMJ open. 2019 Jul 9; 9(7):e029824. [view]
  7. Isiguzo GC, Santo K, Panda R, Mbau L, Mishra SR, Ugwu CN, Virani SS, Odili AN, Atkins ER. Adherence Clubs to Improve Hypertension Management in Nigeria: Clubmeds, a Feasibility Study. Global heart. 2022 Mar 16; 17(1):21. [view]
  8. Tran C, Vo V, Taylor P, Koehn DA, Virani SS, Dixon DL. Adherence to lipid monitoring and its impact on treat intensification of LDL-C lowering therapies at an urban academic medical center. Journal of clinical lipidology. 2022 May 11. [view]
  9. Issa R, Minhas AMK, Ariss RW, Nazir S, Rehman H, Kayani WT, Virani SS. Age-Related Disparity Trends in Stroke-Related Mortality in the United States, 1999 to 2019. The American journal of cardiology. 2022 Apr 15; 169:162-163. [view]
  10. Pokharel Y, Mouhanna F, Nambi V, Virani SS, Hoogeveen R, Alonso A, Heiss G, Coresh J, Mosley T, Gottesman RF, Ballantyne CM, Power MC. ApoB, small-dense LDL-C, Lp(a), LpPLA activity, and cognitive change. Neurology. 2019 May 28; 92(22):e2580-e2593. [view]
  11. Virani SS, Akeroyd JM, Nambi V, Michos ED, Morris PB, Nasir K, Smith SC, Stone NJ, Petersen LA, Ballantyne CM. Applicability and Cost Implications for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Based on the ODYSSEY Outcomes Trial. Circulation. 2019 Jan 15; 139(3):410-412. [view]
  12. Patel J, Pallazola VA, Dudum R, Greenland P, McEvoy JW, Blumenthal RS, Virani SS, Miedema MD, Shea S, Yeboah J, Abbate A, Hundley WG, Karger AB, Tsai MY, Sathiyakumar V, Ogunmoroti O, Cushman M, Savji N, Liu K, Nasir K, Blaha MJ, Martin SS, Al Rifai M. Assessment of Coronary Artery Calcium Scoring to Guide Statin Therapy Allocation According to Risk-Enhancing Factors: The Multi-Ethnic Study of Atherosclerosis. JAMA cardiology. 2021 Oct 1; 6(10):1161-1170. [view]
  13. Krittanawong C, Isath A, Scott CZ, Wang Z, Kaplin S, Jneid H, Lavie CJ, Virani SS. Association Between Cinnamon Consumption and Risk of Cardiovascular Health: A Systematic Review and Meta-Analysis. The American journal of medicine. 2022 Jan 1; 135(1):110-117. [view]
  14. Jia X, Sun C, Tanaka H, Al Rifai M, Aguilar D, Ndumele C, Selvin E, Virani SS, Hoogeveen RC, Heiss G, Ballantyne CM, Nambi V. Association between circulating Galectin-3 and arterial stiffness in older adults. VASA. Zeitschrift fur Gefasskrankheiten. 2021 Nov 1; 50(6):439-445. [view]
  15. Ahmed ST, Mahtta D, Rehman H, Akeroyd J, Al Rifai M, Rodriguez F, Jneid H, Nasir K, Samad Z, Alam M, Petersen LA, Virani SS. Association between frequency of primary care provider visits and evidence-based statin prescribing and statin adherence: Findings from the Veterans Affairs system. American heart journal. 2020 Mar 1; 221:9-18. [view]
  16. Jia X, Al Rifai M, Ramsey DJ, Ahmed ST, Akeroyd JM, Nambi V, Ballantyne CM, Petersen LA, Stone NJ, Virani SS. Association Between Lipid Testing and Statin Adherence in the Veterans Affairs Health System. The American journal of medicine. 2019 Sep 1; 132(9):e693-e700. [view]
  17. Jia X, Gao F, Pickett JK, Al Rifai M, Birnbaum Y, Nambi V, Virani SS, Ballantyne CM. Association Between Omega-3 Fatty Acid Treatment and Atrial Fibrillation in Cardiovascular Outcome Trials: A Systematic Review and Meta-Analysis. Cardiovascular drugs and therapy. 2021 Aug 1; 35(4):793-800. [view]
  18. Mszar R, Mahajan S, Valero-Elizondo J, Yahya T, Sharma R, Grandhi GR, Khera R, Virani SS, Lichtman J, Khan SU, Cainzos-Achirica M, Vahidy FS, Krumholz HM, Nasir K. Association Between Sociodemographic Determinants and Disparities in Stroke Symptom Awareness Among US Young Adults. Stroke. 2020 Dec 1; 51(12):3552-3561. [view]
  19. Gregg LP, Hedayati SS, Yang H, Van Buren PN, Banerjee S, Navaneethan SD, Virani SS, Winkelmayer WC, Alvarez CA. Association of Blood Pressure Variability and Diuretics With Cardiovascular Events in Patients With Chronic Kidney Disease Stages 1-5. Hypertension (Dallas, Tex. : 1979). 2021 Mar 3; 77(3):948-959. [view]
  20. Minhas AMK, Gul S, Sheikh AB, Nazir S, Ahuja KR, Anwar MN, Dani SS, Goel SS, Virani SS, Alam M. Association of Body Mass Index with Outcomes in Patients Undergoing Percutaneous Left Atrial Appendage Closure with the Watchman Device. Current problems in cardiology. 2021 Sep 29; 101009. [view]
  21. Hira RS, Kataruka A, Akeroyd JM, Ramsey DJ, Pokharel Y, Gurm HS, Nasir K, Deswal A, Jneid H, Alam M, Ballantyne CM, Petersen LA, Virani SS. Association of Body Mass Index With Risk Factor Optimization and Guideline-Directed Medical Therapy in US Veterans With Cardiovascular Disease. Circulation. Cardiovascular quality and outcomes. 2019 Jan 1; 12(1):e004817. [view]
  22. Lowenstern A, Navar AM, Li S, Virani SS, Goldberg AC, Louie MJ, Lee LV, Peterson ED, Wang TY. Association of Clinician Knowledge and Statin Beliefs With Statin Therapy Use and Lipid Levels (A Survey of US Practice in the PALM Registry). The American journal of cardiology. 2019 Apr 1; 123(7):1011-1018. [view]
  23. Al Rifai M, Kanaya AM, Kandula NR, Patel J, Al-Mallah MH, Budoff M, Cainzos-Achirica M, Criqui MH, Virani SS. Association of Coronary Artery Calcium Density and Volume With Predicted Atherosclerotic Cardiovascular Disease Risk and Cardiometabolic Risk Factors in South Asians: The Mediators of Atherosclerosis in South Asians Living in America (MASALA) Study. Current problems in cardiology. 2022 Jan 7; 101105. [view]
  24. Okunrintemi V, Khera R, Spatz ES, Salami JA, Valero-Elizondo J, Warraich HJ, Virani SS, Blankstein R, Blaha MJ, Pawlik TM, Dharmarajan K, Krumholz HM, Nasir K. Association of Income Disparities with Patient-Reported Healthcare Experience. Journal of general internal medicine. 2019 Jun 1; 34(6):884-892. [view]
  25. Rana JS, Virani SS, Moffet HH, Liu JY, Coghlan LA, Vasadia J, Ballantyne CM, Karter AJ. Association of Low-Density Lipoprotein Testing After an Atherosclerotic Cardiovascular Event with Subsequent Statin Adherence and Intensification. The American journal of medicine. 2022 May 1; 135(5):603-606. [view]
  26. Hussain A, Sun W, Deswal A, de Lemos JA, McEvoy JW, Hoogeveen RC, Matsushita K, Aguilar D, Bozkurt B, Virani SS, Shah AM, Selvin E, Ndumule C, Ballantyne CM, Nambi V. Association of NT-ProBNP, Blood Pressure, and Cardiovascular Events: The ARIC Study. Journal of the American College of Cardiology. 2021 Feb 9; 77(5):559-571. [view]
  27. Kianoush S, Al Rifai M, Patel J, George J, Gulati M, Taub P, Moran T, Shapiro MD, Agarwala A, Ullah W, Lavie CJ, Bittner V, Ballantyne CM, Virani SS. Association of participation in Cardiac Rehabilitation with Social Vulnerability Index: The behavioral risk factor surveillance system. Progress in Cardiovascular Diseases. 2022 Mar 1; 71:86-91. [view]
  28. Jia X, Lee MT, Ramsey DJ, Mahtta D, Akeroyd JM, Turchin A, Navar AM, Matheny ME, Gobbel G, Stone NJ, Nambi V, Ballantyne CM, Petersen LA, Virani SS. Association of patient, provider and facility related characteristics with statin associated side effects and statin use: Insight from the Veteran's Affairs healthcare system. Journal of clinical lipidology. 2021 Nov 1; 15(6):832-839. [view]
  29. Krittanawong C, Khawaja M, Rosenson RS, Amos CI, Nambi V, Lavie CJ, Virani SS. Association of PCSK9 Variants With the Risk of Atherosclerotic Cardiovascular Disease and Variable Responses to PCSK9 Inhibitor Therapy. Current problems in cardiology. 2022 Jul 1; 47(7):101043. [view]
  30. Jain V, Rifai MA, Brinzevich D, Taj M, Saleh M, Krittanawong C, Patel J, Patel A, Lee MT, Mahtta D, Virani SS. Association of premature atherosclerotic cardiovascular disease with higher risk of cancer: a behavioral risk factor surveillance system study. European journal of preventive cardiology. 2022 Mar 25; 29(3):493-501. [view]
  31. Fu C, Hao W, Shrestha N, Virani SS, Mishra SR, Zhu D. Association of reproductive factors with dementia: A systematic review and dose-response meta-analyses of observational studies. EClinicalMedicine. 2022 Jan 1; 43:101236. [view]
  32. Brunner G, Virani SS, Sun W, Liu L, Dodge RC, Nambi V, Coresh J, Mosley TH, Sharrett AR, Boerwinkle E, Ballantyne CM, Wasserman BA. Associations Between Carotid Artery Plaque Burden, Plaque Characteristics, and Cardiovascular Events: The ARIC Carotid Magnetic Resonance Imaging Study. JAMA cardiology. 2021 Jan 1; 6(1):79-86. [view]
  33. Valero-Elizondo J, Chouairi F, Khera R, Grandhi GR, Saxena A, Warraich HJ, Virani SS, Desai NR, Sasangohar F, Krumholz HM, Esnaola NF, Nasir K. Atherosclerotic Cardiovascular Disease, Cancer, and Financial Toxicity Among Adults in the United States. JACC. CardioOncology. 2021 Jun 1; 3(2):236-246. [view]
  34. Mahtta D, Gupta A, Ramsey DJ, Rifai MA, Mehta A, Krittanawong C, Lee MT, Nasir K, Samad Z, Blumenthal RS, Jneid H, Ballantyne CM, Petersen LA, Virani SS. Autoimmune Rheumatic Diseases and Premature Atherosclerotic Cardiovascular Disease: An Analysis From the VITAL Registry. The American journal of medicine. 2020 Dec 1; 133(12):1424-1432.e1. [view]
  35. Satish P, Vela E, Bilal U, Cleries M, Kanaya AM, Kandula N, Virani SS, Islam N, Valero-Elizondo J, Yahya T, Comin-Colet J, Nasir K, Mauri J, Cainzos-Achirica M. Burden of cardiovascular risk factors and disease in five Asian groups in Catalonia: a disaggregated, population-based analysis of 121 000 first-generation Asian immigrants. European journal of preventive cardiology. 2022 May 6; 29(6):916-924. [view]
  36. Shrestha N, Gautam S, Mishra SR, Virani SS, Dhungana RR. Burden of chronic kidney disease in the general population and high-risk groups in South Asia: A systematic review and meta-analysis. PLoS ONE. 2021 Oct 14; 16(10):e0258494. [view]
  37. Shams P, Hussain M, Karani S, Mahmood S, Hasan A, Siddiqi S, Virani SS, Samad Z. Can Sound Public Health Policies Stem the Tide of Burgeoning Epidemic of Cardiovascular Disease in South Asians? Current Cardiology Reports. 2021 Oct 23; 23(12):181. [view]
  38. Saeed A, Zhu J, Thoma F, Marroquin O, Aiyer A, Agarwala A, Virani SS, Gulati M, Lee JS, Reis S, Saba S, Ballantyne C, Mulukutla S. Cardiovascular Disease Risk-Based Statin Utilization and Associated Outcomes in a Primary Prevention Cohort: Insights From a Large Health Care Network. Circulation. Cardiovascular quality and outcomes. 2021 Sep 1; 14(9):e007485. [view]
  39. Krittanawong C, Kumar A, Hahn J, Wang Z, Zhang HJ, Sun T, Bozkurt B, Ballantyne CM, Virani SS, Halperin JL, Jneid H. Cardiovascular risk and complications associated with COVID-19. American journal of cardiovascular disease. 2020 Oct 15; 10(4):479-489. [view]
  40. Saeed A, Virani SS, Jones PH, Ballantyne CM, Nambi V. Case reports of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition nonresponse. Journal of clinical lipidology. 2018 Sep 1; 12(5):1141-1145. [view]
  41. Merchant AT, Virani SS. Childhood Oral Infections and Subclinical Atherosclerosis in Adulthood: Should We Wait for Causality or Just Treat?. JAMA Network Open. 2019 Apr 5; 2(4):e192489. [view]
  42. Barolia R, Iqbal S, Virani SS, Khan F, Petrucka P. Cigarette smokers' perceptions of smoking cessation and associated factors in Karachi, Pakistan. Public health nursing (Boston, Mass.). 2022 Mar 1; 39(2):381-389. [view]
  43. Jia X, Virani SS. CLEAR Serenity Trial: More Clarity for the Future of Bempedoic Acid in Patients Unable to Take Statins?. Journal of the American Heart Association. 2019 Apr 2; 8(7):e012352. [view]
  44. Minhas AMK, Awan MU, Raza M, Virani SS, Sharma G, Blankstein R, Blaha MJ, Al-Kindi SG, Kaluksi E, Nasir K, Khan SU. Clinical and Economic Burden of Percutaneous Coronary Intervention in Hospitalized Young Adults in the United States, 2004-2018. Current problems in cardiology. 2021 Nov 26; 101070. [view]
  45. Khan SU, Khan MZ, Khan MU, Khan MS, Mamas MA, Rashid M, Blankstein R, Virani SS, Johansen MC, Shapiro MD, Blaha MJ, Cainzos-Achirica M, Vahidy FS, Nasir K. Clinical and Economic Burden of Stroke Among Young, Midlife, and Older Adults in the United States, 2002-2017. Mayo Clinic proceedings. Innovations, quality & outcomes. 2021 Apr 1; 5(2):431-441. [view]
  46. Khan SU, Yedlapati SH, Khan MZ, Virani SS, Blaha MJ, Sharma G, Jordan JE, Kash BA, Vahidy FS, Arshad A, Mossialos E, Nasir K. Clinical and Economic Profile of Homeless Young Adults with Stroke in the United States, 2002-2017. Current problems in cardiology. 2022 Mar 26; 101190. [view]
  47. Krittanawong C, Mahtta D, Narasimhan B, Wang Z, Bandyopadhyay D, Hanif B, Samad Z, Kitai T, Alam M, Sharma SK, Jneid H, Virani SS. Clinical characteristics and mortality after acute myocardial infarction-related hospitalization among Asians from a national population-based cohort study. Progress in Cardiovascular Diseases. 2021 Jul 1; 67:108-110. [view]
  48. Ullah W, Ur Rahman M, Rauf A, Zahid S, Thalambedu N, Mir T, Khan MZ, Fischman DL, Virani S, Alam M. Comparative analysis of revascularization with percutaneous coronary intervention versus coronary artery bypass surgery for patients with end-stage renal disease: a nationwide inpatient sample database. Expert Review of Cardiovascular Therapy. 2021 Aug 1; 19(8):763-768. [view]
  49. Secemsky EA, Butala N, Raja A, Khera R, Wang Y, Curtis JP, Maddox TM, Virani SS, Armstrong EJ, Shunk KA, Brindis RG, Bhatt D, Yeh RW. Comparative Outcomes of Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction Among Medicare Beneficiaries With Multivessel Coronary Artery Disease: An National Cardiovascular Data Registry Research to Practice Project. Circulation. Cardiovascular interventions. 2021 Aug 1; 14(8):e010323. [view]
  50. Lee MT, Mahtta D, Alam M, Ullah W, Nasir K, Hanif B, Virani SS. Contemporary outcomes studies to identify and mitigate the risk in patients with premature cardiovascular disease. Expert review of pharmacoeconomics & outcomes research. 2021 Aug 1; 21(4):559-570. [view]
  51. Rifai MA, Blaha MJ, Patel J, Xiaoming J, Cainzos-Achirica M, Greenland P, Budoff M, Yeboah J, Nasir K, Al-Mallah MH, Virani SS. Coronary Artery Calcification, Statin Use and Long-Term Risk of Atherosclerotic Cardiovascular Disease Events (from the Multi-Ethnic Study of Atherosclerosis). The American journal of cardiology. 2020 Mar 15; 125(6):835-839. [view]
  52. Al Rifai M, Vaughan EM, Abushamat LA, Lee M, Ramsey DJ, Gupta K, Navaneethan SD, Virani SS. Correlates of Glucagon-Like Peptide-1 Receptor Agonist Use Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes Mellitus (from the Department of Veterans Affairs). The American journal of cardiology. 2022 Jun 1; 172:7-10. [view]
  53. Al Rifai M, Mahtta D, Ramsey DJ, Lee MT, Krittanawong C, Navaneethan SD, Gregg LP, Petersen LA, Virani SS. Correlates of SGLT-2-inhibitiors use among patients with atherosclerotic cardiovascular disease and type 2 diabetes mellitus: Insights from the department of veterans affairs. American heart journal. 2022 Jun 1; 248:160-162. [view]
  54. Mszar R, Grandhi GR, Valero-Elizondo J, Caraballo C, Khera R, Desai N, Virani SS, Blankstein R, Blaha MJ, Nasir K. Cumulative Burden of Financial Hardship From Medical Bills Across the Spectrum of Diabetes Mellitus and Atherosclerotic Cardiovascular Disease Among Non-Elderly Adults in the United States. Journal of the American Heart Association. 2020 May 18; 9(10):e015523. [view]
  55. Al Rifai M, Blumenthal RS, Stone NJ, Schofield RS, Orringer CE, Michos ED, Heidenreich PA, Braun L, Birtcher KK, Smith SC, Nambi V, Grundy S, Virani SS. Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) guidelines for management of dyslipidemia and cardiovascular disease risk reduction: Putting evidence in context. Progress in Cardiovascular Diseases. 2021 Sep 1; 68:2-6. [view]
  56. Al Rifai M, Blaha MJ, Nambi V, Shea SJC, Michos ED, Blumenthal RS, Ballantyne CM, Szklo M, Greenland P, Miedema MD, Nasir K, Rotter JI, Guo X, Yao J, Post WS, Virani SS. Determinants of Incident Atherosclerotic Cardiovascular Disease Events Among Those With Absent Coronary Artery Calcium: Multi-Ethnic Study of Atherosclerosis. Circulation. 2022 Jan 25; 145(4):259-267. [view]
  57. Bhugra P, Grandhi GR, Mszar R, Satish P, Singh R, Blaha M, Blankstein R, Virani SS, Cainzos-Achirica M, Nasir K. Determinants of Influenza Vaccine Uptake in Patients With Cardiovascular Disease and Strategies for Improvement. Journal of the American Heart Association. 2021 Aug 3; 10(15):e019671. [view]
  58. Sajja A, Li HF, Spinelli KJ, Blumenthal RS, Virani SS, Martin SS, Gluckman TJ. Discordance Between Standard Equations for Determination of LDL Cholesterol in Patients With Atherosclerosis. Journal of the American College of Cardiology. 2022 Feb 15; 79(6):530-541. [view]
  59. Zhu D, Ozaki A, Virani SS. Disease-Specific Excess Mortality During the COVID-19 Pandemic: An Analysis of Weekly US Death Data for 2020. American journal of public health. 2021 Aug 1; 111(8):1518-1522. [view]
  60. Al Rifai M, Kanaya AM, Kandula NR, Cainzos-Achirica M, Patel J, Budoff M, Criqui MH, Blaha MJ, Virani SS. Distribution of calcium volume, density, number, and type of coronary vessel with calcified plaque in South Asians in the US and other race/ethnic groups: The MASALA and MESA studies. Atherosclerosis. 2021 Jan 1; 317:16-21. [view]
  61. Saeed A, Virani SS, Mulukutla S, Chow CK. Dyslipidemia and Cardiovascular Disease Prevention in South Asians: A Review and Discussion of Causes, Challenges and Management Strategies. Current Diabetes Reviews. 2021 Jan 1; 17(9):e011221190238. [view]
  62. Al Rifai M, Mirbolouk M, Jia X, Nasir K, Pickett JK, Nambi V, Ballantyne CM, Merchant AT, Blaha MJ, Virani SS. E-cigarette Use and Risk Behaviors among Lesbian, Gay, Bisexual, and Transgender Adults: The Behavioral Risk Factor Surveillance System (BRFSS) Survey. Kansas journal of medicine. 2020 Dec 11; 13:318-321. [view]
  63. Yonas E, Alwi I, Pranata R, Huang I, Lim MA, Gutierrez EJ, Yamin M, Siswanto BB, Virani SS. Effect of heart failure on the outcome of COVID-19 - A meta analysis and systematic review. The American journal of emergency medicine. 2021 Aug 1; 46:204-211. [view]
  64. Khan MR, Kayani WT, Ahmad W, Manan M, Hira RS, Hamzeh I, Jneid H, Virani SS, Kleiman N, Lakkis N, Alam M. Effect of increasing age on percutaneous coronary intervention vs coronary artery bypass grafting in older adults with unprotected left main coronary artery disease: A meta-analysis and meta-regression. Clinical Cardiology. 2019 Nov 1; 42(11):1071-1078. [view]
  65. Khan SU, Lone AN, Khan MS, Virani SS, Blumenthal RS, Nasir K, Miller M, Michos ED, Ballantyne CM, Boden WE, Bhatt DL. Effect of omega-3 fatty acids on cardiovascular outcomes: A systematic review and meta-analysis. EClinicalMedicine. 2021 Aug 1; 38:100997. [view]
  66. Gregg LP, Richardson PA, Akeroyd J, Matheny ME, Virani SS, Navaneethan SD. Effects of the 2021 CKD-EPI Creatinine eGFR Equation among a National US Veteran Cohort. Clinical journal of the American Society of Nephrology : CJASN. 2022 Feb 1; 17(2):283-285. [view]
  67. Khan SU, Khan MU, Virani SS, Khan MS, Khan MZ, Rashid M, Kalra A, Alkhouli M, Blaha MJ, Blumenthal RS, Michos ED. Efficacy and safety for the achievement of guideline-recommended lower low-density lipoprotein cholesterol levels: a systematic review and meta-analysis. European journal of preventive cardiology. 2022 Feb 9; 28(18):2001-2009. [view]
  68. Yonas E, Alwi I, Pranata R, Huang I, Lim MA, Yamin M, Nasution SA, Setiati S, Virani SS. Elevated interleukin levels are associated with higher severity and mortality in COVID 19 - A systematic review, meta-analysis, and meta-regression. Diabetes & metabolic syndrome. 2020 Nov 1; 14(6):2219-2230. [view]
  69. Jia X, Akeroyd JM, Nasir K, Nambi V, Ballantyne CM, Petersen LA, Virani SS. Eligibility and Cost for Icosapent Ethyl Based on the REDUCE-IT Trial. Circulation. 2019 Mar 5; 139(10):1341-1343. [view]
  70. Kataruka A, Mahtta D, Akeroyd JM, Hira RS, Kazi DS, Spertus JA, Bhatt DL, Petersen LA, Ballantyne CM, Virani SS. Eligibility for Low-Dose Rivaroxaban Based on the COMPASS Trial: Insights from the Veterans Affairs Healthcare System. Cardiovascular drugs and therapy. 2021 Jun 1; 35(3):533-538. [view]
  71. Mahtta D, Virani S, Bavry AA. Emerging Lipid-Lowering Therapies in Secondary Prevention. Current cardiovascular risk reports. 2019 Apr 17; 13(11):https://doi.org/10.1007/s12170-019-0607-z. [view]
  72. Hussain A, Lee M, Rana J, Virani SS. Epidemiology and risk factors for stroke in young individuals: implications for prevention. Current Opinion in Cardiology. 2021 Sep 1; 36(5):565-571. [view]
  73. Mahtta D, Ramsey DJ, Al Rifai M, Nasir K, Samad Z, Aguilar D, Jneid H, Ballantyne CM, Petersen LA, Virani SS. Evaluation of Aspirin and Statin Therapy Use and Adherence in Patients With Premature Atherosclerotic Cardiovascular Disease. JAMA Network Open. 2020 Aug 3; 3(8):e2011051. [view]
  74. Jain V, Al Rifai M, Turpin R, Eken HN, Agrawal A, Mahtta D, Samad Z, Coulter S, Rodriguez F, Petersen LA, Virani SS. Evaluation of Factors Underlying Sex-Based Disparities in Cardiovascular Care in Adults With Self-reported Premature Atherosclerotic Cardiovascular Disease. JAMA cardiology. 2022 Mar 1; 7(3):341-345. [view]
  75. Mahtta D, Ahmed ST, Shah NR, Ramsey DJ, Akeroyd JM, Nasir K, Hamzeh IR, Elgendy IY, Waldo SW, Al-Mallah MH, Jneid H, Ballantyne CM, Petersen LA, Virani SS. Facility-Level Variation in Cardiac Stress Test Use Among Patients With Diabetes: Findings From the Veterans Affairs National Database. Diabetes Care. 2020 May 1; 43(5):e58-e60. [view]
  76. Jia X, Lee MT, Ramsey DJ, Al Rifai M, Mahtta D, Krittanawong C, Akeroyd JM, Matheny ME, Gobbel G, Stone NJ, Ballantyne CM, Petersen LA, Virani SS. Facility-Level Variation in Reported Statin-Associated Side Effects Among Patients with Atherosclerotic Cardiovascular Disease-Perspective from the Veterans Affair Healthcare System. Cardiovascular drugs and therapy. 2022 Apr 1; 36(2):295-300. [view]
  77. Shah NR, Ahmed ST, Winchester DE, Ramsey DJ, Akeroyd JM, Wu WC, Waldo SW, Schofield RS, Ballantyne CM, Petersen LA, Virani SS. Facility-Level Variation in Stress Test Utilization in Veterans With Ischemic Heart Disease. JACC. Cardiovascular imaging. 2019 Jul 1; 12(7 Pt 1):1292-1293. [view]
  78. Valero-Elizondo J, Khera R, Saxena A, Grandhi GR, Virani SS, Butler J, Samad Z, Desai NR, Krumholz HM, Nasir K. Financial Hardship From Medical Bills Among Nonelderly U.S. Adults With Atherosclerotic Cardiovascular Disease. Journal of the American College of Cardiology. 2019 Feb 19; 73(6):727-732. [view]
  79. Krittanawong C, Isath A, Hahn J, Wang Z, Narasimhan B, Kaplin SL, Jneid H, Virani SS, Tang WHW. Fish Consumption and Cardiovascular Health: A Systematic Review. The American journal of medicine. 2021 Jun 1; 134(6):713-720. [view]
  80. Krittanawong C, Daher M, Hahn J, Narasimhan B, Wang Z, Alam M, Jneid H, Virani SS. Gender Differences in Premature Coronary Artery Disease (from the National Data from the NHANES Database). The American journal of cardiology. 2021 Aug 15; 153:142-144. [view]
  81. Daher M, Al Rifai M, Kherallah RY, Rodriguez F, Mahtta D, Michos ED, Khan SU, Petersen LA, Virani SS. Gender disparities in difficulty accessing healthcare and cost-related medication non-adherence: The CDC behavioral risk factor surveillance system (BRFSS) survey. Preventive medicine. 2021 Dec 1; 153:106779. [view]
  82. Virani SS, Koschinsky ML, Maher L, Mehta A, Orringer CE, Santos RD, Shapiro MD, Saseen JJ. Global think tank on the clinical considerations and management of lipoprotein(a): The top questions and answers regarding what clinicians need to know. Progress in Cardiovascular Diseases. 2022 Jan 19. [view]
  83. Agha AM, Jones PH, Ballantyne CM, Virani SS, Nambi V. Greater than expected reduction in low-density lipoprotein-cholesterol (LDL-C) with bempedoic acid in a patient with heterozygous familial hypercholesterolemia (HeFH). Journal of clinical lipidology. 2021 Sep 1; 15(5):649-652. [view]
  84. Virani SS, Ballantyne CM, Petersen LA. Guideline-Concordant Statin Therapy Use in Secondary Prevention: Should the Medical Community Wait for Divine Intervention? Journal of the American College of Cardiology. 2022 May 10; 79(18):1814-1817. [view]
  85. Rajan SS, Akeroyd JM, Ahmed ST, Ramsey DJ, Ballantyne CM, Petersen LA, Virani SS. Health care costs associated with primary care physicians versus nurse practitioners and physician assistants. Journal of the American Association of Nurse Practitioners. 2021 May 31; 33(11):967-974. [view]
  86. Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Delling FN, Djousse L, Elkind MSV, Ferguson JF, Fornage M, Khan SS, Kissela BM, Knutson KL, Kwan TW, Lackland DT, Lewis TT, Lichtman JH, Longenecker CT, Loop MS, Lutsey PL, Martin SS, Matsushita K, Moran AE, Mussolino ME, Perak AM, Rosamond WD, Roth GA, Sampson UKA, Satou GM, Schroeder EB, Shah SH, Shay CM, Spartano NL, Stokes A, Tirschwell DL, VanWagner LB, Tsao CW, American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association. Circulation. 2020 Mar 3; 141(9):e139-e596. [view]
  87. Tsao CW, Aday AW, Almarzooq ZI, Alonso A, Beaton AZ, Bittencourt MS, Boehme AK, Buxton AE, Carson AP, Commodore-Mensah Y, Elkind MSV, Evenson KR, Eze-Nliam C, Ferguson JF, Generoso G, Ho JE, Kalani R, Khan SS, Kissela BM, Knutson KL, Levine DA, Lewis TT, Liu J, Loop MS, Ma J, Mussolino ME, Navaneethan SD, Perak AM, Poudel R, Rezk-Hanna M, Roth GA, Schroeder EB, Shah SH, Thacker EL, VanWagner LB, Virani SS, Voecks JH, Wang NY, Yaffe K, Martin SS. Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association. Circulation. 2022 Feb 22; 145(8):e153-e639. [view]
  88. Grundy SM, Stone NJ, Blumenthal RS, Braun LT, Heidenreich PA, Lloyd-Jones D, Orringer CE, Saseen JJ, Smith SC, Sperling LS, Virani SS. High-Intensity Statins Benefit High-Risk Patients: Why and How to Do Better. Mayo Clinic proceedings. 2021 Oct 1; 96(10):2660-2670. [view]
  89. Jia X, Al Rifai M, Hussain A, Martin S, Agarwala A, Virani SS. Highlights from Studies in Cardiovascular Disease Prevention Presented at the Digital 2020 European Society of Cardiology Congress: Prevention Is Alive and Well. Current Atherosclerosis Reports. 2020 Oct 3; 22(12):72. [view]
  90. Hussain A, Al Rifai M, Mahtta D, Liu J, Jain V, Virani SS. Highlights from Studies Presented at the American Heart Association Scientific Session 2020: Navigating New Roads in Prevention. Current Atherosclerosis Reports. 2021 Jan 3; 23(1):4. [view]
  91. Jain V, Al Rifai M, Mahtta D, Liu J, Hussain A, Virani SS. Highlights from Studies Presented at the Virtual American College of Cardiology Scientific Sessions 2021: Staying Updated with the Latest Advancements in Prevention. Current Atherosclerosis Reports. 2021 Jul 6; 23(9):50. [view]
  92. Hermel M, Tsai S, Dlouhy L, B K A, Rana JS, Dani SS, Virani SS. Highlights of Cardiovascular Disease Prevention Studies Presented at the 2022 American College of Cardiology Scientific Sessions. Current Atherosclerosis Reports. 2022 Aug 1; 24(8):671-680. [view]
  93. Lee MT, George J, Shahab H, Hermel M, Rana JS, Virani SS. Highlights of Cardiovascular Disease Studies Presented at the 2021 American Heart Association Scientific Sessions. Current Atherosclerosis Reports. 2022 Jan 1; 24(1):61-72. [view]
  94. Lee MT, Mahtta D, Dlouhy L, Shahab H, Al Rifai M, Virani SS. Highlights of Cardiovascular Disease Studies Presented at the 2021 European Society of Cardiology Congress. Current Atherosclerosis Reports. 2021 Oct 14; 23(12):76. [view]
  95. Jia X, Al Rifai M, Liu J, Agarwala A, Gulati M, Virani SS. Highlights of Studies in Cardiovascular Disease Prevention Presented at the 2020 American College of Cardiology Annual Scientific Session. Current Atherosclerosis Reports. 2020 Jun 18; 22(8):32. [view]
  96. Pokharel Y, Mouhanna F, Schneider ALC, Rawlings AM, Knopman DS, Nambi V, Virani SS, Hoogeveen RC, Alonso A, Heiss G, Coresh J, Mosley T, Gottesman R, Selvin E, Ballantyne C, Power MC. High-Sensitive Troponin T, Natriuretic Peptide, and Cognitive Change. Journal of the American Geriatrics Society. 2019 Nov 1; 67(11):2353-2361. [view]
  97. Karagiannis AD, Mehta A, Dhindsa DS, Virani SS, Orringer CE, Blumenthal RS, Stone NJ, Sperling LS. How low is safe? The frontier of very low (<30 mg/dL) LDL cholesterol. European heart journal. 2021 Jun 7; 42(22):2154-2169. [view]
  98. Patel J, Mehta A, Rifai MA, Blaha MJ, Nasir K, McEvoy JW, Pandey A, Kanaya AM, Kandula NR, Virani SS, Abbate A, Hundley G, Sperling L, Joshi PH. Hypertension guidelines and coronary artery calcification among South Asians: Results from MASALA and MESA. American journal of preventive cardiology. 2021 Jun 1; 6:100158. [view]
  99. Kazi DS, Virani SS. Implications of cost-effectiveness analyses of lipid-lowering therapies: From the policy-maker's desk to the patient's bedside. Progress in Cardiovascular Diseases. 2019 Sep 1; 62(5):406-413. [view]
  100. Mahtta D, Rodriguez F, Jneid H, Levine GN, Virani SS. Improving adherence to cardiovascular guidelines: realistic transition from paper to patient. Expert Review of Cardiovascular Therapy. 2020 Jan 1; 18(1):41-51. [view]
  101. Mehta A, Vasquez N, Ayers CR, Patel J, Hooda A, Khera A, Blumenthal RS, Shapiro MD, Rodriguez CJ, Tsai MY, Sperling LS, Virani SS, Blaha MJ, Joshi PH. Independent Association of Lipoprotein(a) and Coronary Artery Calcification With Atherosclerotic Cardiovascular Risk. Journal of the American College of Cardiology. 2022 Mar 1; 79(8):757-768. [view]
  102. Krittanawong C, Narasimhan B, Hahn J, Narasimhan H, Jneid H, Virani SS, Wang Z, Lavie CJ, Arena R, Tang WHW. Individual sentiments on telehealth in the COVID-19 era: Insights from Twitter. Progress in Cardiovascular Diseases. 2022 Apr 27. [view]
  103. Nasir K, Acquah I, Dey AK, Agrawal T, Hassan SZ, Glassner K, Abraham B, Quigley EMM, Blankstein R, Virani SS, Blaha MJ, Valero-Elizondo J, Cainzos-Achirica M, Mehta NN. Inflammatory bowel disease and atherosclerotic cardiovascular disease in U.S. adults-A population-level analysis in the national health interview survey. American journal of preventive cardiology. 2022 Mar 1; 9:100316. [view]
  104. Xian Y, Navar AM, Li S, Li Z, Robinson J, Virani SS, Louie MJ, Koren A, Goldberg A, Roger VL, Wilson PWF, Peterson ED, Wang TY. Intensity of Lipid Lowering With Statin Therapy in Patients With Cerebrovascular Disease Versus Coronary Artery Disease: Insights from the PALM Registry. Journal of the American Heart Association. 2019 Oct 1; 8(19):e013229. [view]
  105. Gobbel GT, Matheny ME, Reeves RR, Akeroyd JM, Turchin A, Ballantyne CM, Petersen LA, Virani SS. Leveraging structured and unstructured electronic health record data to detect reasons for suboptimal statin therapy use in patients with atherosclerotic cardiovascular disease. American journal of preventive cardiology. 2022 Mar 1; 9:100300. [view]
  106. Deshotels MR, Virani SS, Ballantyne CM. Lipid Monitoring After Initiation of Lipid-Lowering Therapies: Return of Performance Measures? Current Cardiology Reports. 2021 Jul 16; 23(9):116. [view]
  107. Jia X, Liu J, Mehta A, Ballantyne CM, Virani SS. Lipid-Lowering Biotechnological Drugs: from Monoclonal Antibodies to Antisense Therapies-a Clinical Perspective. Cardiovascular drugs and therapy. 2021 Dec 1; 35(6):1269-1279. [view]
  108. Saeed A, Kinoush S, Virani SS. Lipoprotein (a): Recent Updates on a Unique Lipoprotein. Current Atherosclerosis Reports. 2021 Jun 19; 23(8):41. [view]
  109. Mehta A, Jain V, Saeed A, Saseen JJ, Gulati M, Ballantyne CM, Virani SS. Lipoprotein(a) and ethnicities. Atherosclerosis. 2022 May 1; 349:42-52. [view]
  110. Saeed A, Sun W, Agarwala A, Virani SS, Nambi V, Coresh J, Selvin E, Boerwinkle E, Jones PH, Ballantyne CM, Hoogeveen RC. Lipoprotein(a) levels and risk of cardiovascular disease events in individuals with diabetes mellitus or prediabetes: The Atherosclerosis Risk in Communities study. Atherosclerosis. 2019 Mar 1; 282:52-56. [view]
  111. Vaughan EM, Johnson E, Naik AD, Amspoker AB, Balasubramanyam A, Virani SS, Ballantyne CM, Johnston CA, Foreyt JP. Long-Term Effectiveness of the TIME Intervention to Improve Diabetes Outcomes in Low-Income Settings: a 2-Year Follow-Up. Journal of general internal medicine. 2022 Feb 7. [view]
  112. Virani SS, Ballantyne CM. Low-Density Lipoprotein Cholesterol: Is 160 the New 190? Circulation. 2018 Nov 20; 138(21):2326-2329. [view]
  113. Kamal AK, Khalid W, Muqeet A, Jamil A, Farhat K, Gillani SRA, Zulfiqar M, Saif M, Muhammad AA, Zaidi F, Mustafa M, Gowani A, Sharif S, Bokhari SS, Tai J, Rahman N, Sultan FAT, Sayani S, Virani SS. Making prescriptions "talk" to stroke and heart attack survivors to improve adherence: Results of a randomized clinical trial (The Talking Rx Study). PLoS ONE. 2018 Dec 20; 13(12):e0197671. [view]
  114. Triozzi JL, Parker Gregg L, Virani SS, Navaneethan SD. Management of type 2 diabetes in chronic kidney disease. BMJ open diabetes research & care. 2021 Jul 1; 9(1). [view]
  115. Saleem S, Ullah W, Syed MA, Megaly M, Thalambedu N, Younas S, Zahid S, Alam M, Virani SS, Verma DR, Abdul-Waheed M, Fischman DL. Meta-analysis comparing valve-in-valve TAVR and redo-SAVR in patients with degenerated bioprosthetic aortic valve. Catheterization and Cardiovascular Interventions : Official Journal of The Society For Cardiac Angiography & Interventions. 2021 Nov 1; 98(5):940-947. [view]
  116. Mahtta D, Altibi A, Gad MM, Samara A, Barakat AF, Bagur R, Mansoor H, Jneid H, Virani SS, Mamas MA, Masri A, Elgendy IY. Methodological Rigor and Temporal Trends of Cardiovascular Medicine Meta-Analyses in Highest-Impact Journals. Journal of the American Heart Association. 2021 Sep 21; 10(18):e021367. [view]
  117. Dixon DL, Virani SS. Mortality reduction with PCSK9 inhibition: A case of cautious optimism. Journal of clinical lipidology. 2019 Sep 1; 13(5):712-713. [view]
  118. Krittanawong C, Isath A, Hahn J, Wang Z, Fogg SE, Bandyopadhyay D, Jneid H, Virani SS, Tang WHW. Mushroom Consumption and Cardiovascular Health: A Systematic Review. The American journal of medicine. 2021 May 1; 134(5):637-642.e2. [view]
  119. Tibuakuu M, Okunrintemi V, Savji N, Stone NJ, Virani SS, Blankstein R, Thamman R, Blumenthal RS, Michos ED. Nondietary Cardiovascular Health Metrics With Patient Experience and Loss of Productivity Among US Adults Without Cardiovascular Disease: The Medical Expenditure Panel Survey 2006 to 2015. Journal of the American Heart Association. 2020 Oct 20; 9(19):e016744. [view]
  120. Kamran H, Jneid H, Kayani WT, Virani SS, Levine GN, Nambi V, Khalid U. Oral Antiplatelet Therapy After Acute Coronary Syndrome: A Review. JAMA. 2021 Apr 20; 325(15):1545-1555. [view]
  121. Lowenstern A, Li S, Navar AM, Virani SS, Roger VL, Robinson JG, Goldberg AC, Kampman W, Peterson ED, Wang TY. Patient perceptions and use of non-statin lipid lowering therapy among patients with or at risk for atherosclerotic cardiovascular disease: Insights from the PALM registry. Clinical Cardiology. 2021 Jun 1; 44(6):863-870. [view]
  122. Navar AM, Wang TY, Li S, Mi X, Li Z, Robinson JG, Virani SS, Peterson ED. Patient-Perceived Versus Actual Risk of Cardiovascular Disease and Associated Willingness to Consider and Use Prevention Therapy. Circulation. Cardiovascular quality and outcomes. 2021 Jan 1; 14(1):e006548. [view]
  123. Bradley CK, Wang TY, Li S, Robinson JG, Roger VL, Goldberg AC, Virani SS, Louie MJ, Lee LV, Peterson ED, Navar AM. Patient-Reported Reasons for Declining or Discontinuing Statin Therapy: Insights From the PALM Registry. Journal of the American Heart Association. 2019 Apr 2; 8(7):e011765. [view]
  124. Ullah W, Thalambedu N, Zahid S, Zia Khan M, Mir T, Roomi S, Fischman DL, Virani SS, Alam M. Percutaneous coronary intervention in patients with cardiac allograft vasculopathy: a Nationwide Inpatient Sample (NIS) database analysis. Expert Review of Cardiovascular Therapy. 2021 Mar 1; 19(3):269-276. [view]
  125. Agarwala A, Kohli P, Virani SS. Popular Media and Cardiovascular Medicine: "with Great Power There Must Also Come Great Responsibility". Current Atherosclerosis Reports. 2019 Oct 31; 21(11):43. [view]
  126. Hira RS, Gosch KL, Kazi DS, Yeh RW, Kataruka A, Maddox TM, Shah T, Jneid H, Bhatt DL, Virani SS. Potential Impact of the 2019 ACC/AHA Guidelines on the Primary Prevention of Cardiovascular Disease Recommendations on the Inappropriate Routine Use of Aspirin and Aspirin Use Without a Recommended Indication for Primary Prevention of Cardiovascular Disease in Cardiology Practices: Insights From the NCDR PINNACLE Registry. Circulation. Cardiovascular quality and outcomes. 2022 Mar 1; 15(3):e007979. [view]
  127. Nanna MG, Navar AM, Wang TY, Li S, Virani SS, Li Z, Robinson JG, Roger VL, Wilson PWF, Goldberg AC, Koren A, Louie MJ, Peterson ED. Practice-level variation in statin use and low-density lipoprotein cholesterol control in the United States: Results from the Patient and Provider Assessment of Lipid Management (PALM) registry. American heart journal. 2019 Aug 1; 214:113-124. [view]
  128. Al Rifai M, Itchhaporia D, Virani SS. Pragmatic Clinical Trials-Ready for Prime Time? JAMA Network Open. 2021 Dec 1; 4(12):e2140212. [view]
  129. Ullah W, Jafar M, Zahid S, Ahmed F, Khan MZ, Sattar Y, Fischman DL, Virani SS, Alam M. Predictors of In-Hospital Mortality in Patients With End-Stage Renal Disease Undergoing Transcatheter Aortic Valve Replacement: A Nationwide Inpatient Sample Database Analysis. Cardiovascular revascularization medicine : including molecular interventions. 2022 Jan 1; 34:63-68. [view]
  130. Blumenthal DM, Maddox TM, Aragam K, Sacks CA, Virani SS, Wasfy JH. Predictors of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibitor Prescriptions for Secondary Prevention of Clinical Atherosclerotic Cardiovascular Disease. Circulation. Cardiovascular quality and outcomes. 2021 Sep 1; 14(9):e007237. [view]
  131. Lee MT, Mahtta D, Chen L, Hussain A, Al Rifai M, Sinh P, Khalid U, Nasir K, Ballantyne CM, Petersen LA, Virani SS. Premature Atherosclerotic Cardiovascular Disease Risk Among Patients with Inflammatory Bowel Disease. The American journal of medicine. 2021 Aug 1; 134(8):1047-1051.e2. [view]
  132. Al Rifai M, Mahtta D, Kherallah R, Kianoush S, Liu J, Rodriguez F, Nasir K, Valero J, Khan SU, Ballantyne C, Petersen LA, Virani SS. Prevalence and Determinants of Difficulty in Accessing Medical Care in U.S. Adults. American journal of preventive medicine. 2021 Oct 1; 61(4):492-500. [view]
  133. Kherallah R, Al Rifai M, Kamat I, Krittanawong C, Mahtta D, Lee MT, Liu J, Nasir K, Valero-Elizondo J, Patel J, Al-Mallah MH, Petersen LA, Virani SS. Prevalence and predictors of cost-related medication nonadherence in individuals with cardiovascular disease: Results from the Behavioral Risk Factor Surveillance System (BRFSS) survey. Preventive medicine. 2021 Dec 1; 153:106715. [view]
  134. Kianoush S, Rifai MA, Jain V, Samad Z, Rana J, Dodani S, Jia X, Lee M, Khan SU, Gupta K, Lavie CJ, Wong SS, Palla AH, Virani S. Prevalence and Predictors of Premature Coronary Heart Disease Among Asians in the United States: A National Health Interview Survey Study. Current problems in cardiology. 2022 Feb 26; 101152. [view]
  135. Agrawal T, Acquah I, Dey AK, Glassner K, Abraham B, Blankstein R, Virani SS, Blaha MJ, Valero-Elizondo J, Mehta N, Quigley EM, Cainzos-Achirica M, Nasir K. Prevalence of cardiovascular risk factors in a nationally representative adult population with inflammatory bowel disease without atherosclerotic cardiovascular disease. American journal of preventive cardiology. 2021 Jun 1; 6:100171. [view]
  136. Mahtta D, Daher M, Lee MT, Sayani S, Shishehbor M, Virani SS. Promise and Perils of Telehealth in the Current Era. Current Cardiology Reports. 2021 Jul 16; 23(9):115. [view]
  137. Sardana M, Tang Y, Magnani JW, Ockene IS, Allison JJ, Arnold SV, Jones PG, Maddox TM, Virani SS, McManus DD. Provider-Level Variation in Smoking Cessation Assistance Provided in the Cardiology Clinics: Insights From the NCDR PINNACLE Registry. Journal of the American Heart Association. 2019 Jul 2; 8(13):e011412. [view]
  138. Al Rifai M, Khalid U, Misra A, Liu J, Nasir K, Cainzos-Achirica M, Mahtta D, Ballantyne CM, Petersen LA, Virani SS. Racial and geographic disparities in influenza vaccination in the U.S. among individuals with atherosclerotic cardiovascular disease: Renewed importance in the setting of COVID-19. American journal of preventive cardiology. 2021 Mar 1; 5:100150. [view]
  139. Jain V, Al Rifai M, Lee MT, Kalra A, Petersen LA, Vaughan EM, Wong ND, Ballantyne CM, Virani SS. Racial and Geographic Disparities in Internet Use in the U.S. Among Patients With Hypertension or Diabetes: Implications for Telehealth in the Era of COVID-19. Diabetes Care. 2021 Jan 1; 44(1):e15-e17. [view]
  140. Gu K, Mahtta D, Kaneria A, Sharedalal P, Dennis B, Song Y, Wei X, Khalid U, Hess P, Cho SH, Virani SS. Racial disparities among Asian Americans with atrial fibrillation: An analysis from the NCDR® PINNACLE Registry. International Journal of Cardiology. 2021 Apr 15; 329:209-216. [view]
  141. Mhanna M, Minhas AMK, Ariss RW, Nazir S, Khan SU, Vaduganathan M, Blankstein R, Alam M, Nasir K, Virani SS. Racial Disparities in Clinical Outcomes and Resource Utilization of Type 2 Myocardial Infarction in the United States: Insights From the National Inpatient Sample Database. Current problems in cardiology. 2022 Apr 8; 101202. [view]
  142. Krittanawong C, Yue B, Mahtta D, Narasimhan B, Kumar A, Wang Z, Sharma SK, Tamis-Holland JE, Brar SS, Mehran R, Alam M, Jneid H, Virani SS. Readmission in Patients With ST-Elevation Myocardial Infarction in 4 Age Groups (<45, >45 to <60, 60 to <75, and >75). The American journal of cardiology. 2022 Jun 15; 173:25-32. [view]
  143. Mahtta D, Ramsey D, Krittanawong C, Al Rifai M, Khurram N, Samad Z, Jneid H, Ballantyne C, Petersen LA, Virani SS. Recreational substance use among patients with premature atherosclerotic cardiovascular disease. Heart (British Cardiac Society). 2021 Apr 1; 107(8):650-656. [view]
  144. Borden WB, Wang J, Jones P, Tang Y, Contreras J, Daugherty SL, Desai NR, Virani SS, Wasfy JH, Maddox TM. Reducing Cardiovascular Risk in the Medicare Million Hearts Risk Reduction Model: Insights From the National Cardiovascular Data Registry PINNACLE Registry. Circulation. Cardiovascular quality and outcomes. 2022 Apr 1; 15(4):e007908. [view]
  145. Rehman H, Ahmed ST, Akeroyd J, Mahtta D, Jia X, Rifai MA, Nasir K, Jneid H, Khalid MU, Alam M, Toth PP, Virani SS. Relation Between Cardiology Follow-Up Visits, Evidence-Based Statin Prescribing, and Statin Adherence (from the Veterans Affairs Health Care System). The American journal of cardiology. 2019 Oct 15; 124(8):1165-1170. [view]
  146. Khera R, Secemsky EA, Wang Y, Desai NR, Krumholz HM, Maddox TM, Shunk KA, Virani SS, Bhatt DL, Curtis J, Yeh RW. Revascularization Practices and Outcomes in Patients With Multivessel Coronary Artery Disease Who Presented With Acute Myocardial Infarction and Cardiogenic Shock in the US, 2009-2018. JAMA internal medicine. 2020 Oct 1; 180(10):1317-1327. [view]
  147. Hyman DA, Siebert V, Jia X, Alam M, Levine GN, Virani SS, Birnbaum Y. Risk Assessment of Stroke in Patients with Atrial Fibrillation: Current Shortcomings and Future Directions. Cardiovascular drugs and therapy. 2019 Feb 1; 33(1):105-117. [view]
  148. Ullah W, Haq S, Zahid S, Gowda SN, Ottman P, Saleem S, Hamzeh I, Virani SS, Alam M, Fischman DL. Safety and Efficacy of Colchicine in Patients with Stable CAD and ACS: A Systematic Review and Meta-analysis. American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions. 2021 Nov 1; 21(6):659-668. [view]
  149. Feldman DI, Michos ED, Stone NJ, Gluckman TJ, Cainzos-Achirica M, Virani SS, Blumenthal RS. Same evidence, varying viewpoints: Three questions illustrating important differences between United States and European cholesterol guideline recommendations. American journal of preventive cardiology. 2020 Dec 1; 4:100117. [view]
  150. Mahajan S, Grandhi GR, Valero-Elizondo J, Mszar R, Khera R, Acquah I, Yahya T, Virani SS, Blankstein R, Blaha MJ, Cainzos-Achirica M, Nasir K. Scope and Social Determinants of Food Insecurity Among Adults With Atherosclerotic Cardiovascular Disease in the United States. Journal of the American Heart Association. 2021 Aug 17; 10(16):e020028. [view]
  151. Virani SS, Smith SC, Stone NJ, Grundy SM. Secondary Prevention for Atherosclerotic Cardiovascular Disease: Comparing Recent US and European Guidelines on Dyslipidemia. Circulation. 2020 Apr 7; 141(14):1121-1123. [view]
  152. Rehman H, Kalra A, Kochar A, Uberoi AS, Bhatt DL, Samad Z, Virani SS. Secondary prevention of cardiovascular diseases in India: Findings from registries and large cohorts. Indian heart journal. 2020 Sep 1; 72(5):337-344. [view]
  153. Okunrintemi V, Tibuakuu M, Virani SS, Sperling LS, Volgman AS, Gulati M, Cho L, Leucker TM, Blumenthal RS, Michos ED. Sex Differences in the Age of Diagnosis for Cardiovascular Disease and Its Risk Factors Among US Adults: Trends From 2008 to 2017, the Medical Expenditure Panel Survey. Journal of the American Heart Association. 2020 Dec 15; 9(24):e018764. [view]
  154. Dong C, Zhou C, Fu C, Hao W, Ozaki A, Shrestha N, Virani SS, Mishra SR, Zhu D. Sex differences in the association between cardiovascular diseases and dementia subtypes: a prospective analysis of 464,616 UK Biobank participants. Biology of sex differences. 2022 May 7; 13(1):21. [view]
  155. Nanna MG, Wang TY, Xiang Q, Goldberg AC, Robinson JG, Roger VL, Virani SS, Wilson PWF, Louie MJ, Koren A, Li Z, Peterson ED, Navar AM. Sex Differences in the Use of Statins in Community Practice. Circulation. Cardiovascular quality and outcomes. 2019 Aug 16; 12(8):e005562. [view]
  156. Lee MT, Mahtta D, Ramsey DJ, Liu J, Misra A, Nasir K, Samad Z, Itchhaporia D, Khan SU, Schofield RS, Ballantyne CM, Petersen LA, Virani SS. Sex-Related Disparities in Cardiovascular Health Care Among Patients With Premature Atherosclerotic Cardiovascular Disease. JAMA cardiology. 2021 Jul 1; 6(7):782-790. [view]
  157. Okunrintemi V, Valero-Elizondo J, Stone NJ, Blankstein R, Blaha MJ, Gulati M, Virani SS, Zoghbi WA, Michos ED, Nasir K. Shared decision making and patient reported outcomes among adults with atherosclerotic cardiovascular disease, medical expenditure panel survey 2006-2015. American journal of preventive cardiology. 2021 Dec 1; 8:100281. [view]
  158. Ahmed ST, Akeroyd JM, Mahtta D, Street R, Slagle J, Navar AM, Stone NJ, Ballantyne CM, Petersen LA, Virani SS. Shared Decisions: A Qualitative Study on Clinician and Patient Perspectives on Statin Therapy and Statin-Associated Side Effects. Journal of the American Heart Association. 2020 Nov 17; 9(22):e017915. [view]
  159. Mahtta D, Lee MT, Ramsey DJ, Akeroyd JM, Krittanawong C, Khan SU, Sinh P, Alam M, Garratt KN, Schofield RS, Ballantyne CM, Petersen LA, Virani SS. Significant Facility-Level Variation in Utilization of and Adherence with Secondary Prevention Therapies Among Patients with Premature Atherosclerotic Cardiovascular Disease: Insights from the VITAL (Veterans wIth premaTure AtheroscLerosis) Registry7. Cardiovascular drugs and therapy. 2022 Feb 1; 36(1):93-102. [view]
  160. Khan SU, Acquah I, Javed Z, Valero-Elizondo J, Yahya T, Blankstein R, Virani SS, Blaha MJ, Hyder AA, Dubey P, Vahidy FS, Cainzos-Achirica M, Nasir K. Social Determinants of Health Among Non-Elderly Adults With Stroke in the United States. Mayo Clinic proceedings. 2022 Feb 1; 97(2):238-249. [view]
  161. Jilani MH, Javed Z, Yahya T, Valero-Elizondo J, Khan SU, Kash B, Blankstein R, Virani SS, Blaha MJ, Dubey P, Hyder AA, Vahidy FS, Cainzos-Achirica M, Nasir K. Social Determinants of Health and Cardiovascular Disease: Current State and Future Directions Towards Healthcare Equity. Current Atherosclerosis Reports. 2021 Jul 26; 23(9):55. [view]
  162. Al Rifai M, Jia X, Pickett J, Hussain A, Navaneethan SD, Birtcher KK, Ballantyne C, Petersen LA, Virani SS. Social Determinants of Health and Comorbidities Among Individuals with Atherosclerotic Cardiovascular Disease: The Behavioral Risk Factor Surveillance System Survey. Population health management. 2022 Feb 1; 25(1):39-45. [view]
  163. Javed Z, Valero-Elizondo J, Maqsood MH, Mahajan S, Taha MB, Patel KV, Sharma G, Hagan K, Blaha MJ, Blankstein R, Mossialos E, Virani SS, Cainzos-Achirica M, Nasir K. Social determinants of health and obesity: Findings from a national study of US adults. Obesity (Silver Spring, Md.). 2022 Feb 1; 30(2):491-502. [view]
  164. Krittanawong C, Kaplin S, Tang WHW, Jneid H, Virani SS, Messerli FH. Social media and predictive analysis regarding dietary approaches to stop hypertension. Progress in Cardiovascular Diseases. 2021 Sep 1; 68:88-90. [view]
  165. Al Rifai M, Jain V, Khan SU, Nasir K, Zhu D, Vasudeva R, Lavie CJ, Dodani S, Petersen LA, Virani SS. Social vulnerability and COVID-19: An analysis of CDC data. Progress in Cardiovascular Diseases. 2021 Sep 22. [view]
  166. Khan SU, Javed Z, Lone AN, Dani SS, Amin Z, Al-Kindi SG, Virani SS, Sharma G, Blankstein R, Blaha MJ, Cainzos-Achirica M, Nasir K. Social Vulnerability and Premature Cardiovascular Mortality Among US Counties, 2014 to 2018. Circulation. 2021 Oct 19; 144(16):1272-1279. [view]
  167. Grandhi GR, Mszar R, Vahidy F, Valero-Elizondo J, Blankstein R, Blaha MJ, Virani SS, Andrieni JD, Omer SB, Nasir K. Sociodemographic Disparities in Influenza Vaccination Among Adults With Atherosclerotic Cardiovascular Disease in the United States. JAMA cardiology. 2021 Jan 1; 6(1):87-91. [view]
  168. Mishra SR, Ghimire S, Shrestha N, Shrestha A, Virani SS. Socio-economic inequalities in hypertension burden and cascade of services: nationwide cross-sectional study in Nepal. Journal of Human Hypertension. 2019 Aug 1; 33(8):613-625. [view]
  169. Hussain A, Tang O, Sun C, Jia X, Selvin E, Nambi V, Folsom A, Heiss G, Zannad F, Mosley T, Virani SS, Coresh J, Boerwinkle E, Yu B, Cunningham JW, Shah AM, Solomon SD, de Lemos JA, Hoogeveen RC, Ballantyne CM. Soluble Angiotensin-Converting Enzyme 2, Cardiac Biomarkers, Structure, and Function, and Cardiovascular Events (from the Atherosclerosis Risk in Communities Study). The American journal of cardiology. 2021 May 1; 146:15-21. [view]
  170. Al Rifai M, Jain V, Khan SU, Bk A, Mahar JH, Krittanawong C, Mishra SR, Dani SS, Petersen LA, Virani SS. State-Level Social Vulnerability Index and Healthcare Access: The Behavioral Risk Factor Surveillance System Survey. American journal of preventive medicine. 2022 Apr 30. [view]
  171. Jain V, Rifai MA, Naderi S, Barolia R, Iqbal S, Taj M, Jia X, Merchant AT, Aronow WS, Virani SS. State-Level Temporal Trends in Smokeless Tobacco and Cigarette Use Among U.S. Adults. The American journal of cardiology. 2021 Mar 1; 142:145-147. [view]
  172. Mahtta D, Ahmed ST, Ramsey DJ, Akeroyd JM, Lee MT, Rodriguez F, Michos ED, Itchhaporia D, Nasir K, Alam M, Jneid H, Ballantyne CM, Petersen LA, Virani SS. Statin Prescription Rates, Adherence, and Associated Clinical Outcomes Among Women with PAD and ICVD. Cardiovascular drugs and therapy. 2020 Dec 1; 34(6):745-754. [view]
  173. Jia X, Virani SS. Statins in COVID-19 infection: A rehash of old themes or truly a new hope? Journal of clinical lipidology. 2021 May 1; 15(3):399-401. [view]
  174. Isath A, Howard CE, Virani SS, Wang Z, Lavie CJ, Naidu SS, Krittanawong C. Strength training and cardiovascular health: A meta-analysis. Progress in Cardiovascular Diseases. 2022 May 5. [view]
  175. Khan SU, Kalra A, Yedlapati SH, Dani SS, Shapiro MD, Nasir K, Virani SS, Michos ED, Alkhouli M. Stroke-Related Mortality in the United States-Mexico Border Area of the United States, 1999 to 2018. Journal of the American Heart Association. 2021 Jul 6; 10(13):e019993. [view]
  176. Daher M, Al Rifai M, Mahtta D, Krittanawong C, Berman J, Ullah W, Alam M, Virani SS. Substance Use and Premature Atherosclerotic Cardiovascular Disease (From the CDC Behavioral Risk Factor Surveillance System [BRFSS] Survey). The American journal of cardiology. 2021 Aug 1; 152:177-178. [view]
  177. Gupta MD, Miglani M, Bansal A, Jain V, Arora S, Kumar S, Virani SS, Kalra A, Yadav R, Pasha Q, Yusuf J, Mukhopadhyay S, Tyagi S, Girish MP. Telomere length in young patients with acute myocardial infarction without conventional risk factors: A pilot study from a South Asian population. Indian heart journal. 2020 Nov 1; 72(6):619-622. [view]
  178. Wu L, Narasimhan B, Bhatia K, Ho KS, Krittanawong C, Aronow WS, Lam P, Virani SS, Pamboukian SV. Temporal Trends in Characteristics and Outcomes Associated With In-Hospital Cardiac Arrest: A 20-Year Analysis (1999-2018). Journal of the American Heart Association. 2021 Dec 7; 10(23):e021572. [view]
  179. Al Rifai M, Kianoush S, Saeed A, Krittanawong C, Merchant AT, Virani SS. Temporal Trends in the Prevalence of Current E-Cigarette and Cigarette Use by Annual Household Income from 2016 to 2018 (from the Behavioral Risk Factor Surveillance System [BRFSS] Survey). The American journal of cardiology. 2020 Dec 15; 137:139-140. [view]
  180. Bays HE, Taub PR, Epstein E, Michos ED, Ferraro RA, Bailey AL, Kelli HM, Ferdinand KC, Echols MR, Weintraub H, Bostrom J, Johnson HM, Hoppe KK, Shapiro MD, German CA, Virani SS, Hussain A, Ballantyne CM, Agha AM, Toth PP. Ten things to know about ten cardiovascular disease risk factors. American journal of preventive cardiology. 2021 Mar 1; 5:100149. [view]
  181. Jia X, Al Rifai M, Birnbaum Y, Smith SC, Virani SS. The 2018 Cholesterol Management Guidelines: Topics in Secondary ASCVD Prevention Clinicians Need to Know. Current Atherosclerosis Reports. 2019 Apr 2; 21(6):20. [view]
  182. Al Rifai M, Mirbolouk M, Obisesan OH, Jia X, Nasir K, Merchant AT, Blaha M, Virani S. The Association of Electronic Cigarette Use and the Subjective Domains of Physical and Mental Health: The Behavioral Risk Factor Surveillance System Survey. Cureus. 2020 Feb 24; 12(2):e7088. [view]
  183. Sandesara PB, Virani SS, Fazio S, Shapiro MD. The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk. Endocrine reviews. 2019 Apr 1; 40(2):537-557. [view]
  184. Kamal AK, Khalid W, Zulfiqar M, Muqeet A, Zaidi F, Gowani A, Virani SS. The potential of m-Health-based interventions to improve medication literacy and adherence in non-communicable diseases in Pakistan. International journal of stroke : official journal of the International Stroke Society. 2019 Apr 1; 14(3):NP8-NP10. [view]
  185. Al Rifai M, Virani SS. The Reply. The American journal of medicine. 2020 Oct 1; 133(10):e608. [view]
  186. Haddadin F, Arevalo AB, Jabri A, Beydoun H, Fram F, Munoz Estrella A, Karim S, Virani S, Ali Y. The risk and severity of stroke in patients with atrial fibrillation and gout: A National Representative Database study. Journal of arrhythmia. 2021 Apr 1; 37(2):394-399. [view]
  187. Agarwala A, Michos ED, Samad Z, Ballantyne CM, Virani SS. The Use of Sex-Specific Factors in the Assessment of Women's Cardiovascular Risk. Circulation. 2020 Feb 18; 141(7):592-599. [view]
  188. Virani SS, Al Rifai M. The Utility of Coronary Artery Calcium for Guiding Treatment With Preventive Pharmacotherapy: Opportunities and Nuances. JACC. Cardiovascular imaging. 2022 Apr 1; 15(4):652-654. [view]
  189. Liu J, Saeed A, Hussain A, Virani SS. The Way to a Woman's Heart: Assessing, Personalizing, and Reclassifying Atherosclerotic Cardiovascular Disease Risk in Female Patients. Texas Heart Institute journal. 2020 Apr 1; 47(2):125-127. [view]
  190. Dixon DL, Sharma G, Sandesara PB, Yang E, Braun LT, Mensah GA, Sperling LS, Deedwania PC, Virani SS. Therapeutic Inertia in Cardiovascular Disease Prevention: Time to Move the Bar. Journal of the American College of Cardiology. 2019 Oct 1; 74(13):1728-1731. [view]
  191. Quispe R, Elshazly MB, Zhao D, Toth PP, Puri R, Virani SS, Blumenthal RS, Martin SS, Jones SR, Michos ED. Total cholesterol/HDL-cholesterol ratio discordance with LDL-cholesterol and non-HDL-cholesterol and incidence of atherosclerotic cardiovascular disease in primary prevention: The ARIC study. European journal of preventive cardiology. 2020 Oct 1; 27(15):1597-1605. [view]
  192. Ullah W, Zahid S, Hamzeh I, Birnbaum Y, Virani SS, Alam M. Trends and Predictors of Transcatheter Aortic Valve Implantation Related In-Hospital Mortality (From the National Inpatient Sample Database). The American journal of cardiology. 2021 Mar 15; 143:97-103. [view]
  193. Minhas AMK, Ijaz SH, Jamal S, Dani SS, Khan MS, Greene SJ, Fudim M, Warraich HJ, Shapiro MD, Virani SS, Nasir K, Khan SU. Trends in Characteristics and Outcomes in Primary Heart Failure Hospitalizations Among Older Population in the United States, 2004 to 2018. Circulation. Heart failure. 2022 May 1; 15(5):e008943. [view]
  194. Dani SS, Minhas AMK, Arshad A, Krupica T, Goel SS, Virani SS, Sharma G, Blankstein R, Blaha MJ, Al-Kindi SG, Nasir K, Khan SU. Trends in Characteristics and Outcomes of Hospitalized Young Patients Undergoing Coronary Artery Bypass Grafting in the United States, 2004 to 2018. Journal of the American Heart Association. 2021 Sep 7; 10(17):e021361. [view]
  195. Gupta K, Viacava RC, Jain V, Kakar TS, Jesse M, Virani SS. Trends in Patient-Recalled Targets for Cardiovascular Risk Factors in Ambulatory US Adults With Diabetes Mellitus (from National Health and Nutrition Examination Survey). The American journal of cardiology. 2022 Feb 1; 164:143-145. [view]
  196. Narasimhan B, Kaplin SL, Narasimhan H, Wang Z, Bandyopadhyay D, Jneid H, Virani SS, Krittanawong C. Trends in pneumococcal vaccination in patients presenting with acute coronary syndrome in the United States. Progress in Cardiovascular Diseases. 2021 Jul 1; 67:111-113. [view]
  197. Dani SS, Lone AN, Javed Z, Khan MS, Zia Khan M, Kaluski E, Virani SS, Shapiro MD, Cainzos-Achirica M, Nasir K, Khan SU. Trends in Premature Mortality From Acute Myocardial Infarction in the United States, 1999 to 2019. Journal of the American Heart Association. 2022 Jan 4; 11(1):e021682. [view]
  198. Gupta K, Obeidat L, Kakar TS, Fadel RA, Al Rifai M, Abushamat LA, Virani SS. Trends in Undiagnosed Diabetes Mellitus Among United States Adults: Cross-Sectional Analyses from NHANES 2011-2020. The American journal of cardiology. 2022 Jul 15; 175:184-185. [view]
  199. Hussain A, Ballantyne CM, Saeed A, Virani SS. Triglycerides and ASCVD Risk Reduction: Recent Insights and Future Directions. Current Atherosclerosis Reports. 2020 Jun 3; 22(7):25. [view]
  200. Trang A, Kampangkaew J, Fernandes R, Tiwana J, Misra A, Hamzeh I, Blaustein A, Aguilar D, Shah T, Ballantyne C, Quinones M, Nagueh SF, Dokanish H, Virani SS, Deswal A, Kirkpatrick JN, Nambi V. Understanding by General Providers of the Echocardiogram Report. The American journal of cardiology. 2019 Jul 15; 124(2):296-302. [view]
  201. Hess PL, Gosch KL, Jani SM, Varosy PD, Bradley SM, Maddox TM, Michael Ho P, Virani SS. Use of oral anticoagulants in patients with valvular atrial fibrillation: findings from the NCDR PINNACLE Registry. American heart journal. 2021 Oct 1; 240:58-62. [view]
  202. Kianoush S, Al-Rifai M, Kalra A, Bk A, Mehta A, Sadaf MI, Misra A, Khalid U, Lavie CJ, Kayani WT, Virani SS. Use of preventive cardiovascular health care among Asian American individuals: A National Health Interview Survey Study. Current problems in cardiology. 2022 May 2; 101241. [view]
  203. Lloyd-Jones DM, Braun LT, Ndumele CE, Smith SC, Sperling LS, Virani SS, Blumenthal RS. Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease: A Special Report From the American Heart Association and American College of Cardiology. Circulation. 2019 Jun 18; 139(25):e1162-e1177. [view]
  204. Lloyd-Jones DM, Braun LT, Ndumele CE, Smith SC, Sperling LS, Virani SS, Blumenthal RS. Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease: A Special Report From the American Heart Association and American College of Cardiology. Journal of the American College of Cardiology. 2019 Jun 25; 73(24):3153-3167. [view]
  205. Mahtta D, Ramsey DJ, Lee MT, Chen L, Al Rifai M, Akeroyd JM, Vaughan EM, Matheny ME, Santo KRDE, Navaneethan SD, Lavie CJ, Birnbaum Y, Ballantyne CM, Petersen LA, Virani SS. Utilization Rates of SGLT2 Inhibitors and GLP-1 Receptor Agonists and Their Facility-Level Variation Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes: Insights From the Department of Veterans Affairs. Diabetes Care. 2022 Feb 1; 45(2):372-380. [view]
  206. Rodwin BA, Salami JA, Spatz ES, Valero-Elizondo J, Virani SS, Blankstein R, Blaha MJ, Nasir K, Desai NR. Variation in the Use of Warfarin and Direct Oral Anticoagulants in Atrial Fibrillation and Associated Cost Implications. The American journal of medicine. 2019 Jan 1; 132(1):61-70.e1. [view]
  207. Virani SS, Akeroyd JM, Smith SC, Al-Mallah M, Maddox TM, Morris PB, Petersen LA, Ballantyne CM, Grundy SM, Stone NJ. Very High-Risk ASCVD and Eligibility for Nonstatin Therapies Based on the 2018 AHA/ACC Cholesterol Guidelines. Journal of the American College of Cardiology. 2019 Aug 6; 74(5):712-714. [view]


DRA: Cardiovascular Disease
DRE: Prevention, Prognosis, Treatment - Implementation
Keywords: Best Practices, Care Management Tools, Implementation
MeSH Terms: none

Questions about the HSR&D website? Email the Web Team.

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.